RE: Philips JV20 Sep 2025 09:33
Philips and Polarean, a medical imaging technology leader in advanced MRI of lung function, today announced the next phase of their strategic partnership to increase access to advanced, radiation-free lung MRI for patients with obstructive lung diseases. By expanding multi-nuclei imaging with Xenon MRI, the collaboration enables clinicians to better detect and monitor lung conditions like asthma and cystic fibrosis. Unlike standard imaging, this new technique, using hyperpolarized Xenon gas as a signaling agent, allows clinicians to see how air flows through different parts of the lungs in real time, providing critical insight that was previously invisible. Xenon MRI is already FDA-approved for evaluating lung ventilation in adults and children aged 12 and older. Pending FDA approval for children as young as six, this collaboration is a major step toward earlier detection and safer, long-term disease monitoring, without the risks associated with radiation exposure.